Advertisement

Drug Delivery and Translational Research

, Volume 9, Issue 3, pp 625–630 | Cite as

Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency

  • Merav Jacobson Bensky
  • Irit Ayalon-Dangur
  • Roi Ayalon-Dangur
  • Eviatar Naamany
  • Anat Gafter-Gvili
  • Gideon Koren
  • Shachaf ShiberEmail author
Original Article

Abstract

There are several methods to treat vitamin B12 deficiency (VB12d): intramuscular (IM), oral, sublingual (SL), and intranasal vitamin B12 (VB12) preparations. Large studies comparing the efficacy of SL vs. IM supplements are lacking. The aim of the present study was to compare the efficacy of SL versus the standard IM administration of VB12 in restoring B12 levels. This was a retrospective analysis of data from the computerized pharmacy records of Maccabi Health Service (MHS). Data were recorded for all patients older than 18 years of age who were prescribed VB12 during January 2014–December 2017. The main outcome was the change in levels of serum vitamin B12 (sVB12) after treatment. Overall, there were 4281 patients treated with VB12 supplements. Of them, 830 (19.3%) patients were treated with VB12 IM injections and 3451 (80.7%) with SL tablets. The mean ± SD difference between sVB12 levels before and after administration of VB12 supplements was significantly higher in the SL group vs. IM injection group (252 ± 223 vs. 218 ± 184 ng/L, p < 0.001). SL VB12 significantly increased the odds ratio (OR) for an increase of sVB12 levels, compared to the IM group, OR 1.85, CI 95% 1.5–2.3, p < 0.001. This is the largest study that documents therapy with SL preparations of VB12 sufficient and even superior to the IM route. The SL overcomes the challenges of IM injections and should be the first line option for patients with VB12d.

Keywords

Vitamin B12 Intramuscular (IM) Oral Sublingual (SL) Efficacy 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226 http://www.ncbi.nlm.nih.gov/pubmed/25189324. Accessed May 3, 2018.CrossRefGoogle Scholar
  2. 2.
    American Dietetic Association, Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. J Am Diet Assoc. 2003;103(6):748–65.  https://doi.org/10.1053/jada.2003.50142.CrossRefGoogle Scholar
  3. 3.
    Institute of Medicine Food and Nutrition Board. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, VB12, pantothenic acid, biotin and choline. Washington, DC: NationalAcademies Press; 1998.Google Scholar
  4. 4.
    Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr. 2004;24(1):299–326.  https://doi.org/10.1146/annurev.nutr.24.012003.132440.CrossRefGoogle Scholar
  5. 5.
    Stabler SP. Megaloblastic anemias: pernicious anemia and folate deficiency. In: Young NS, Gerson SL, High KA, editors. Clinical hematology. Philadelphia: Mosby; 2006. p. 242–51.Google Scholar
  6. 6.
    Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60.  https://doi.org/10.1056/NEJMcp1113996.CrossRefGoogle Scholar
  7. 7.
    Moleiro J, Mão de Ferro S, Ferreira S, Serrano M, Silveira M, Dias Pereira A. Efficacy of long-term Oral vitamin B12 supplementation after total gastrectomy: results from a prospective study. GE Port J Gastroenterol. 2018;25(3):117–22.  https://doi.org/10.1159/000481860.CrossRefGoogle Scholar
  8. 8.
    Kim H-I, Hyung WJ, Song KJ, Choi SH, Kim C-B, Noh SH. Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol. 2011;18(13):3711–7.  https://doi.org/10.1245/s10434-011-1764-6.CrossRefGoogle Scholar
  9. 9.
    Goroll A. Primary care medicine. Boston: Wolter Kluwer Helath; 2014.Google Scholar
  10. 10.
    Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003;25(12):3124–34.  https://doi.org/10.1016/S0149-2918(03)90096-8.CrossRefGoogle Scholar
  11. 11.
    Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92(4):1191–8 http://www.ncbi.nlm.nih.gov/pubmed/9694707. Accessed July 27, 2017.Google Scholar
  12. 12.
    Rajan S, Wallace JI, Brodkin KI, Beresford SA, Allen RH, Stabler SP. Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc. 2002;50(11):1789–95 http://www.ncbi.nlm.nih.gov/pubmed/12410896. Accessed May 27, 2018.CrossRefGoogle Scholar
  13. 13.
    Vidal-Alaball J, Butler C, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005;3:CD004655.  https://doi.org/10.1002/14651858.CD004655.pub2.Google Scholar
  14. 14.
    Kotilea K, Quennery S, Decroës V, Hermans DA. Successful sublingual cobalamin treatment in a child with short-bowel syndrome. J Pediatr Pharmacol Ther. 2014;19(1):60–3.  https://doi.org/10.5863/1551-6776-19.1.60.Google Scholar
  15. 15.
    Delpre G, Stark P, Niv Y, Stabler S, Lindenbaum J. Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation. Lancet (London, England). 1999;354(9180):740–1.  https://doi.org/10.1016/S0140-6736(99)02479-4.CrossRefGoogle Scholar
  16. 16.
    Parry-Strong A, Langdana F, Haeusler S, Weatherall M, Krebs J. Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomised trial. N Z Med J. 2016;129(1436):67–75 http://www.ncbi.nlm.nih.gov/pubmed/27355231. Accessed July 27, 2017.Google Scholar
  17. 17.
    Sharabi A, Cohen E, Sulkes J, Garty M. Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route. Br J Clin Pharmacol. 2003;56(6):635–8.  https://doi.org/10.1046/J.1365-2125.2003.01907.X.CrossRefGoogle Scholar
  18. 18.
    Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008;112(6):2214–21.  https://doi.org/10.1182/blood-2008-03-040253.CrossRefGoogle Scholar
  19. 19.
    Lederle FA. Oral cobalamin for pernicious anemia. Medicine’s best kept secret? JAMA. 1991;265(1):94–5 http://www.ncbi.nlm.nih.gov/pubmed/2064638. Accessed May 27, 2018.CrossRefGoogle Scholar
  20. 20.
    Andrès E, Noel E, Kaltenbach G. Comment: treatment of vitamin B 12 deficiency anemia: oral versus parenteral therapy. Ann Pharmacother. 2002;36(11):1809–10.  https://doi.org/10.1345/aph.1A122a.CrossRefGoogle Scholar
  21. 21.
    Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate. Clin Chem. 2000;46(8 Pt 2):1277–83 http://www.ncbi.nlm.nih.gov/pubmed/10926922. Accessed May 27, 2018.Google Scholar

Copyright information

© Controlled Release Society 2019

Authors and Affiliations

  1. 1.Family DivisionMaccabi Healthcare ServicesTel-AvivIsrael
  2. 2.Internal Medicine Department, Ward ERabin Medical CenterPetach TikvaIsrael
  3. 3.Faculty of Engineering SciencesBen-Gurion University of the NegevBeershebaIsrael
  4. 4.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael
  5. 5.Internal Medicine A, and Davidoff Cancer Center, Institute of HematologyRabin Medical CenterPetach TikvaIsrael
  6. 6.The Maccabi-Kahn Institute of Research and InnovationTel AvivIsrael
  7. 7.The Department of Emergency MedicineRabin Medical CenterPetah TikvaIsrael

Personalised recommendations